Abstract:Dual-mode signal output platforms have demonstrated considerable promise due to their improved anti-interference capability and inherent signal self-correction. Nevertheless, traditional discrete-distributed signal probes often encounter significant drawbacks, including limited mass transfer efficiency, diminished signal strength, and instability in intricate biochemical environments. In response to these challenges, a scalable and hyper-compacted 3D DNA nanoplatform resembling "periodic focusing heliostat" has been developed for synergistically enhanced fluorescence (FL) and surface-enhanced Raman spectroscopy (SERS) biosensing of miRNA in cancer cells. Our approach utilized a distinctive assembly strategy integrating gold nanostars (GNS) as fundamental "heliostat units" linked by palindromic DNA sequences to facilitate each other hand-in-hand cascade alignment and condensed into large scale nanostructures. This configuration was further augmented by the incorporation of gold nanoparticles (GNP) via strong Au-S bonds, resulting in a sturdy framework for improved signal transduction. The initiation of this assembly process was mediated by the hybridization of dsDNA to miRNA-21, which served as a primer for polymerization and nicking reactions, thus generating a multifunctional T2 probe. This probe is intricately designed with three distinct parts: a 3'-palindromic end for structural integrity, a central region for capturing SERS-active probes (Cy3-P2), and a 5'-segment for attaching fluorescence reporters. Upon integration T2 into the GNS-based heliostat unit, it promotes palindromic arm-induced aggregation and plasma exciton coupling between plasma nanoparticles and signal transduction tags. This clustered arrangement creates a high-density "hot spot" array that maximizes the local electromagnetic fields necessary for enhanced SERS and FL response. This superstructure supports enhanced aggregation-induced signal amplification for both SERS and FL, offering exceptional sensitivity with LOD as low as 0.0306 pM and 0.409 pM. The efficacy of this method was demonstrated in the evaluation of miRNA-21 in various cancer cell lines.

Development and application of novel BiFC probes for cell sorting based on epigenetic modification

A superior strategy for single-cell mutational screening via multiplex-targeted QPCR using the BioMark HD microfluidic platform.

Identifying distinct heterochromatin regions using combinatorial epigenetic probes in live cells

Microfluidic cell sorting by stiffness to examine heterogenic responses of cancer cells to chemotherapy

Single-cell CUT&Tag analysis of chromatin modifications in differentiation and tumor progression

Multi-shell structured fluorescent-magnetic nanoprobe for target cell imaging and on-chip sorting.

Functional Tumor Targeting Nano-Systems for Reprogramming Circulating Tumor Cells with In Situ Evaluation on Therapeutic Efficiency at the Single-Cell Level

Aptamer-Based Cell-Surface Profiling with Single-Cell Resolution Enables Precise Cancer Characterization

Chip-Assisted Single-Cell Biomarker Profiling of Heterogeneous Circulating Tumor Cells Using Multifunctional Nanospheres

Cell sorting based on single nucleotide variation enables characterization of mutation-dependent transcriptome and chromatin states.

Development of Microfluidic Platform to High-Throughput Quantify Single-Cell Intrinsic Bioelectrical Markers of Tumor Cell Lines, Subtypes and Patient Tumor Cells

Single-cell multi-modal chromatin profiles revealing epigenetic regulations of cells in hepatocellular carcinoma

Multiomic characterization and drug testing establish circulating tumor cells as an ex vivo tool for personalized medicine

Optical Tweezers Assisted Analyzing and Sorting of Tumor Cells Tagged with Fluorescence Nanospheres in a Microfluidic Chip

A multiparametric fluorescent visualization approach for detecting drug resistance in living cancer cells

Engineered decomposable multifunctional nanobioprobes for capture and release of rare cancer cells.

Liquid biopsy epigenomic profiling for cancer subtyping

Comprehensive in Situ Co-Detection of Aneuploid Circulating Endothelial and Tumor Cells

Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior

An Integrated Microfluidic Chip System for Single-Cell Secretion Profiling of Rare Circulating Tumor Cells

An advanced 3D DNA nanoplatform for spatiotemporally confined enhanced dual-mode biosensing MicroRNA in cancer cell